Food and Drug Administration approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast
Category: Neutropenia
Verzenio for treating breast cancer
Verzenio (abemaciclib) is approved to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative
Aliqopa for treating follicular lymphoma
Aliqopa drug (copanlisib) is for the treatment of adults with relapsed follicular lymphoma who have received systemic therapies. For patients
